Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.

NCT07229027 is registered in ClinicalTrials.gov with Medialis Ltd. as lead sponsor.

NCT NCT07229027
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07229027 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Global Overweight and oBesE (GLOBE) Patient Registry, Development and Implementation of Disease-specific: Severity, Quality of Life and Cost Instruments.
Lead sponsor
Medialis Ltd.
Phase
Observational
Overall status
Recruiting
Start date
November 1, 2025
Completion date
August 31, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight, overweight (bmi > 25)